Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 30, 2026 10:13 ET | Source: Block & Leviton LLP

Corcept Therapeutics Investigated for Securities Fraud Following Report of FDA Warnings; Shareholders Should Contact Block & Leviton To Recover Losses

Corcept Therapeutics (CORT) under investigation following report of previous FDA warnings. Block & Leviton encourages investors to contact the firm.